Cargando…

Mannose synergizes with chemoradiotherapy to cure cancer via metabolically targeting HIF‐1 in a novel triple‐negative glioblastoma mouse model

Detalles Bibliográficos
Autores principales:	Liu, Feng, Xu, Xiaohong, Li, Chunyang, Li, Chunyan, Li, Yuanjun, Yin, Songlin, Yu, Shangbin, Chen, Xiao Qian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648968/ https://www.ncbi.nlm.nih.gov/pubmed/33252849 http://dx.doi.org/10.1002/ctm2.226

Ejemplares similares

Augmentation of Extracellular ATP Synergizes With Chemotherapy in Triple Negative Breast Cancer
por: Manouchehri, Jasmine M., et al.
Publicado: (2022)

The Role of Factor Inhibiting HIF (FIH-1) in Inhibiting HIF-1 Transcriptional Activity in Glioblastoma Multiforme
por: Wang, Enfeng, et al.
Publicado: (2014)

Synergism of a novel MCL-1 downregulator, acriflavine, with navitoclax (ABT-263) in triple-negative breast cancer, lung adenocarcinoma and glioblastoma multiforme
por: Lee, Anbok, et al.
Publicado: (2021)

Vaccine targeting HIF1A in triple negative breast cancer
por: Cecil, Denise, et al.
Publicado: (2014)

The Future of Glioblastoma Therapy: Synergism of Standard of Care and Immunotherapy
por: Patel, Mira A., et al.
Publicado: (2014)

D-mannose facilitates immunotherapy and radiotherapy of triple-negative breast cancer via degradation of PD-L1
por: Zhang, Ruonan, et al.
Publicado: (2022)

Estrogen receptor β2 induces proliferation and invasiveness of triple negative breast cancer cells: association with regulation of PHD3 and HIF-1α
por: Bialesova, Lucia, et al.
Publicado: (2017)

Hif-1α and Hif-2α synergize to suppress AML development but are dispensable for disease maintenance
por: Vukovic, Milica, et al.
Publicado: (2015)

Piperlongumine Induces Apoptosis and Synergizes with Doxorubicin by Inhibiting the JAK2-STAT3 Pathway in Triple-Negative Breast Cancer
por: Chen, Di, et al.
Publicado: (2019)

D-mannose ameliorates autoimmune phenotypes in mouse models of lupus
por: Wang, Haiting, et al.
Publicado: (2021)

Prexasertib treatment induces homologous recombination deficiency and synergizes with olaparib in triple-negative breast cancer cells
por: Mani, Chinnadurai, et al.
Publicado: (2019)

Polo-like kinase 1 (Plk1) inhibition synergizes with taxanes in triple negative breast cancer
por: Giordano, Antonio, et al.
Publicado: (2019)

Metabolic consequences of HIF silencing in a triple negative human breast cancer xenograft
por: Bharti, Santosh K., et al.
Publicado: (2018)

The Microtubule Destabilizer Eribulin Synergizes with STING Agonists to Promote Antitumor Efficacy in Triple-Negative Breast Cancer Models
por: Takahashi-Ruiz, Leila, et al.
Publicado: (2022)

Targeting EIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer
por: Zhao, Na, et al.
Publicado: (2023)

Myeloid Cell Leukemia 1 Small Molecule Inhibitor S63845 Synergizes with Cisplatin in Triple-Negative Breast Cancer
por: Acton, Alexus, et al.
Publicado: (2023)

Unraveling Heterogeneity of Tumor Cells and Microenvironment and Its Clinical Implications for Triple Negative Breast Cancer
por: Jiang, Ke, et al.
Publicado: (2021)

XBP1 Promotes Triple Negative Breast Cancer By Controlling the HIF1 α Pathway
por: Chen, Xi, et al.
Publicado: (2014)

ZHX2 promotes HIF1α oncogenic signaling in triple-negative breast cancer
por: Fang, Wentong, et al.
Publicado: (2021)

HIF and COX-2 expression in triple negative breast cancer cells with hypoxia and 5-fluorouracil
por: Mori, Noriko, et al.
Publicado: (2020)

Chemoradiotherapy Alters Protein Expression in Glioblastoma Multiforme
por: Hwang, Mina, et al.
Publicado: (2020)

ZIP10 is a negative determinant for anti-tumor effect of mannose in thyroid cancer by activating phosphate mannose isomerase
por: Ma, Sharui, et al.
Publicado: (2021)

Postoperative standard chemoradiotherapy benefits primary glioblastoma patients of all ages
por: Li, Guanzhang, et al.
Publicado: (2019)

The LINK-A lncRNA Activates Normoxic HIF1α Signaling in Triple-negative Breast Cancer
por: Lin, Aifu, et al.
Publicado: (2016)

D‐mannose alleviates osteoarthritis progression by inhibiting chondrocyte ferroptosis in a HIF‐2α‐dependent manner
por: Zhou, Xueman, et al.
Publicado: (2021)

Numerical Analysis of Curing Residual Stress and Deformation in Thermosetting Composite Laminates with Comparison between Different Constitutive Models
por: Dai, Jianfeng, et al.
Publicado: (2019)

Harnessing Nuclear Energy to Gold Nanoparticles for the Concurrent Chemoradiotherapy of Glioblastoma
por: Li, Jui-Ping, et al.
Publicado: (2023)

Identification by Comprehensive Bioinformatics Analysis of KIF15 as a Candidate Risk Gene for Triple-Negative Breast Cancer
por: Sheng, Jiayu, et al.
Publicado: (2020)

EBF1 promotes triple-negative breast cancer progression by surveillance of the HIF1α pathway
por: Qiu, Zhaoping, et al.
Publicado: (2022)

RNF8–CDH1 Co-Expression Predicts Clinical Benefit of Chemoradiotherapy in Triple-Negative Breast Cancer
por: Kao, Chieh-Ni, et al.
Publicado: (2021)

Primary Chemoradiotherapy Treatment (PCRT) for HER2+ and Triple Negative Breast Cancer Patients: A Feasible Combination
por: Ciérvide, Raquel, et al.
Publicado: (2022)

Systems modeling accurately predicts responses to genotoxic agents and their synergism with BCL-2 inhibitors in triple negative breast cancer cells
por: Lucantoni, Federico, et al.
Publicado: (2018)

Lupeol synergizes with 5-fluorouracil to combat c-MET/EphA2 mediated chemoresistance in triple negative breast cancer
por: Mitra, Debarpan, et al.
Publicado: (2023)

Oncolytic myxoma virus synergizes with standard of care for treatment of glioblastoma multiforme
por: Burton, Chase, et al.
Publicado: (2018)

Piperlongumine conquers temozolomide chemoradiotherapy resistance to achieve immune cure in refractory glioblastoma via boosting oxidative stress-inflamation-CD8(+)-T cell immunity
por: Liu, Feng, et al.
Publicado: (2023)

Co-targeting the IGF system and HIF-1 inhibits migration and invasion by (triple-negative) breast cancer cells
por: Mancini, M, et al.
Publicado: (2014)

Hypoxia induces docetaxel resistance in triple-negative breast cancer via the HIF-1α/miR-494/Survivin signaling pathway
por: Li, Hongchang, et al.
Publicado: (2022)

Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer
por: Qiu, Jingdan, et al.
Publicado: (2016)

Src Inhibition Can Synergize with Gemcitabine and Reverse Resistance in Triple Negative Breast Cancer Cells via the AKT/c-Jun Pathway
por: Wu, Zhen-Hua, et al.
Publicado: (2016)

T4 cervical esophageal cancer cured with modern chemoradiotherapy: A case report
por: Lee, Chia Ching, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8iut5abcim5ib6t5ck3rc2rog2